New pill could cut seizures in half for epilepsy patients
NCT ID NCT07563881
First seen May 04, 2026 · Last updated May 17, 2026 · Updated 4 times
Summary
This study tests an experimental drug, RAP-219, in 333 adults with focal seizures (a type of epilepsy). Participants will take the drug or a placebo for several weeks to see if it safely reduces how often seizures happen. The goal is to find a new treatment option for people whose seizures are not fully controlled by current medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amicis Research Center
RECRUITINGPalmdale, California, 91324, United States
Conditions
Explore the condition pages connected to this study.